<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">For this network-based approach for drug combinations to be effective, we need to establish if the topological relationship between two drug–target modules reflects biological and pharmacological relationships, while also quantifying their network-based relationship between drug targets and HCoV-associated host proteins (drug–drug–HCoV combinations). To identify potential drug combinations, we combined the top lists of drugs. Then, “separation” measure 
 <italic>S</italic>
 <sub>
  <italic>AB</italic>
 </sub> was calculated for each pair of drugs 
 <italic>A</italic> and 
 <italic>B</italic> using the following method:
 <disp-formula id="Equ3">
  <label>3</label>
  <alternatives>
   <tex-math id="M7">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$S_{AB} = \left\langle {d_{AB}} \right\rangle - \frac{{\left\langle {d_{AA}} \right\rangle + \left\langle {d_{BB}} \right\rangle }}{2},$$\end{document}</tex-math>
   <math id="M8">
    <mrow>
     <msub>
      <mrow>
       <mi>S</mi>
      </mrow>
      <mrow>
       <mi>A</mi>
       <mi>B</mi>
      </mrow>
     </msub>
     <mo>=</mo>
     <mfenced close="⟩" open="⟨" separators="">
      <mrow>
       <msub>
        <mrow>
         <mi>d</mi>
        </mrow>
        <mrow>
         <mi>A</mi>
         <mi>B</mi>
        </mrow>
       </msub>
      </mrow>
     </mfenced>
     <mo>−</mo>
     <mfrac>
      <mrow>
       <mfenced close="⟩" open="⟨" separators="">
        <mrow>
         <msub>
          <mrow>
           <mi>d</mi>
          </mrow>
          <mrow>
           <mi>A</mi>
           <mi>A</mi>
          </mrow>
         </msub>
        </mrow>
       </mfenced>
       <mo>+</mo>
       <mfenced close="⟩" open="⟨" separators="">
        <mrow>
         <msub>
          <mrow>
           <mi>d</mi>
          </mrow>
          <mrow>
           <mi>B</mi>
           <mi>B</mi>
          </mrow>
         </msub>
        </mrow>
       </mfenced>
      </mrow>
      <mrow>
       <mn>2</mn>
      </mrow>
     </mfrac>
     <mo>,</mo>
    </mrow>
   </math>
   <graphic xlink:href="41421_2020_153_Article_Equ3.gif" position="anchor" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </alternatives>
 </disp-formula>where 
 <inline-formula id="IEq2">
  <alternatives>
   <tex-math id="M9">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\left\langle {d_ \cdot } \right\rangle$$\end{document}</tex-math>
   <math id="M10">
    <mfenced close="⟩" open="⟨" separators="">
     <mrow>
      <msub>
       <mrow>
        <mi>d</mi>
       </mrow>
       <mrow>
        <mo>⋅</mo>
       </mrow>
      </msub>
     </mrow>
    </mfenced>
   </math>
   <inline-graphic xlink:href="41421_2020_153_Article_IEq2.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </alternatives>
 </inline-formula> was calculated based on the “closest” method. Our key methodology is that a drug combination is therapeutically effective only if it follows a specific relationship to the disease module, as captured by 
 <italic>Complementary Exposure</italic> patterns in targets’ modules of both drugs without overlapping toxic mechanisms
 <sup>
  <xref ref-type="bibr" rid="CR28">28</xref>
 </sup>.
</p>
